Sharon Bio-Medicine

quarterly
yearly
ParticularsMar '22Jun '22Sep '22Dec '22Mar '23
Revenue50.9038.5656.0159.8445.02
Expenses46.2139.6747.1850.3743.22
EBITDA7.501.5711.5512.394.31
EBIT4.70-1.098.879.481.82
Profit Before Tax4.68-1.118.859.471.81
Net Profit4.68-1.118.859.471.81
Financial Ratios
Operating Profit Margin15.47%4.25%21.41%21.97%10.02%
Net Profit Margin9.64%-3.01%16.40%16.79%4.21%
Earning Per Share (Diluted)8.13-1.9315.3716.453.14
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.4.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ